Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III fixed-dose trial of bugufuran capsules for generalized anxiety disorder
CTR20231405Phase 3Active
- Sponsor
- Institute of Medical Biotechnology, Chinese Academy of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buagafuran in generalized anxiety disorder (GAD), sponsored by Institute of Medical Biotechnology, Chinese Academy of Medical Sciences. Started Jul 2023; status: active.
02
Drugs
buagafuran
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on CTR20231405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231405.